PV: Clinical Use of Hydroxyurea Published 2018-04-26 Download video MP4 360p Download video MP4 720p Recommendations 16:19 Latest on Current Treatments for Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia 08:19 How Do I Know If Hydroxyurea is Not Right for Me? 05:54 Sickle Cell Patients and Hydroxyurea Treatment 04:31 Understanding Parkinson's disease 02:59 Using Hydroxyurea in a Patient With Polycythemia Vera 05:21 Challenges in the treatment and management of ET and the need to improve therapeutic approaches 19:49 What is the Current Standard of Care in Treating Polycythemia Vera (PV)? 03:27 Polycythemia Vera: Signs and Symptoms 08:43 Hydroxyurea in Sickle Cell Disease 19:01 Master clinical history taking (with patient example) 05:46 Iron Supplements Mnemonic for Nursing Pharmacology (NCLEX) 27:59 The Hydroxyurea decision 1:09:45 Living With Polycythemia Vera 31:51 Lung Cancer Breakout: Breakthrough treatments for longer life 04:42 Essential Thrombocytosis 08:53 Sickle cell anemia - causes, symptoms, diagnosis, treatment & pathology 23:14 Why is Hydroxyurea First Line Therapy in the US for Essential Thrombocythemia? 09:43 Polycythemia vera: When to move from hydroxyurea to second-line therapy 13:08 Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa 03:14 What Are Treatment Options for Essential Thrombocythemia? Similar videos 20:15 Hydroxyurea Intolerance/Resistance in Polycythemia vera 09:19 Debate: Should JAK Inhibitors use be Limited to Hydroxyurea-resistant/intolerant PV Patients? - No 17:54 Current therapy options and clinical outcomes analysis in patients with PV 00:57 Moving Beyond Hydroxyurea in Polycythemia Vera 05:50 Machine-learning to predict hydroxyurea failure & thromboembolic events in polycythemia vera 33:02 Dr. John Mascarenhas, MD - PV Moving Beyond Hydroxyurea 15:55 Debate: Should JAK Inhibitors use be Limited to Hydroxyurea-resistant/intolerant PV Patients? - Yes 01:40 Challenges and options for patients with hydroxyurea-resistant PV 02:55 PV-AIM: using machine learning to predict resistance to hydroxyurea therapy in patients with PV 05:14 Case 1: A PV Patient with Disease Progression on Hydroxyurea 04:36 Treatment for PV: Moving Beyond Hydroxyurea 01:16 Treating with hydroxyurea 17:31 How Do You Treat PV Patients That Fail Hydroxyurea (HU)? 06:37 Case 2: A PV Patient with Intolerance to Hydroxyurea 06:49 The Efficacy and Safety of Hydroxyurea Therapy Vs.Switching to Ruxolitinib in PV Patients More results